These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8626577)

  • 1. Role of aromatic transmembrane residues of the delta-opioid receptor in ligand recognition.
    Befort K; Tabbara L; Kling D; Maigret B; Kieffer BL
    J Biol Chem; 1996 Apr; 271(17):10161-8. PubMed ID: 8626577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive activation of the delta opioid receptor by mutations in transmembrane domains III and VII.
    Befort K; Zilliox C; Filliol D; Yue S; Kieffer BL
    J Biol Chem; 1999 Jun; 274(26):18574-81. PubMed ID: 10373467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The conserved aspartate residue in the third putative transmembrane domain of the delta-opioid receptor is not the anionic counterpart for cationic opiate binding but is a constituent of the receptor binding site.
    Befort K; Tabbara L; Bausch S; Chavkin C; Evans C; Kieffer B
    Mol Pharmacol; 1996 Feb; 49(2):216-23. PubMed ID: 8632752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 3D model of the delta opioid receptor and ligand-receptor complexes.
    Alkorta I; Loew GH
    Protein Eng; 1996 Jul; 9(7):573-83. PubMed ID: 8844829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: exploring the "address" recognition locus.
    Metzger TG; Paterlini MG; Ferguson DM; Portoghese PS
    J Med Chem; 2001 Mar; 44(6):857-62. PubMed ID: 11300867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints.
    Pogozheva ID; Lomize AL; Mosberg HI
    Biophys J; 1998 Aug; 75(2):612-34. PubMed ID: 9675164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular docking reveals a novel binding site model for fentanyl at the mu-opioid receptor.
    Subramanian G; Paterlini MG; Portoghese PS; Ferguson DM
    J Med Chem; 2000 Feb; 43(3):381-91. PubMed ID: 10669565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single residue, aspartic acid 95, in the delta opioid receptor specifies selective high affinity agonist binding.
    Kong H; Raynor K; Yasuda K; Moe ST; Portoghese PS; Bell GI; Reisine T
    J Biol Chem; 1993 Nov; 268(31):23055-8. PubMed ID: 8226821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel "restoration of function" mutagenesis strategy to identify amino acids of the delta-opioid receptor involved in ligand binding.
    Pepin MC; Yue SY; Roberts E; Wahlestedt C; Walker P
    J Biol Chem; 1997 Apr; 272(14):9260-7. PubMed ID: 9083060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D modeling, ligand binding and activation studies of the cloned mouse delta, mu; and kappa opioid receptors.
    Filizola M; Laakkonen L; Loew GH
    Protein Eng; 1999 Nov; 12(11):927-42. PubMed ID: 10585498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of conserved aromatic residues essential for agonist binding and second messenger production at 5-hydroxytryptamine2A receptors.
    Roth BL; Shoham M; Choudhary MS; Khan N
    Mol Pharmacol; 1997 Aug; 52(2):259-66. PubMed ID: 9271348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring deltorphin II binding to the third extracellular loop of the delta-opioid receptor.
    Fadhil I; Schmidt R; Walpole C; Carpenter KA
    J Biol Chem; 2004 May; 279(20):21069-77. PubMed ID: 14999000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of Trp-284, Val-296, and Val-297 of the human delta-opioid receptor in binding of delta-selective ligands.
    Valiquette M; Vu HK; Yue SY; Wahlestedt C; Walker P
    J Biol Chem; 1996 Aug; 271(31):18789-96. PubMed ID: 8702536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A unique binding epitope for salvinorin A, a non-nitrogenous kappa opioid receptor agonist.
    Kane BE; Nieto MJ; McCurdy CR; Ferguson DM
    FEBS J; 2006 May; 273(9):1966-74. PubMed ID: 16640560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A conserved aromatic lock for the tryptophan rotameric switch in TM-VI of seven-transmembrane receptors.
    Holst B; Nygaard R; Valentin-Hansen L; Bach A; Engelstoft MS; Petersen PS; Frimurer TM; Schwartz TW
    J Biol Chem; 2010 Feb; 285(6):3973-3985. PubMed ID: 19920139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of determinants of ligand binding affinity and selectivity in the prostaglandin D2 receptor CRTH2.
    Hata AN; Lybrand TP; Breyer RM
    J Biol Chem; 2005 Sep; 280(37):32442-51. PubMed ID: 16030019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of the δ-opioid receptor bound to naltrindole.
    Granier S; Manglik A; Kruse AC; Kobilka TS; Thian FS; Weis WI; Kobilka BK
    Nature; 2012 May; 485(7398):400-4. PubMed ID: 22596164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of ligand selectivity at the kappa-receptor based on the structure of the orphanin FQ receptor.
    Owens CE; Akil H
    J Pharmacol Exp Ther; 2002 Mar; 300(3):992-9. PubMed ID: 11861808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding sites and transduction process of the cholecystokininB receptor: involvement of highly conserved aromatic residues of the transmembrane domains evidenced by site-directed mutagenesis.
    Jagerschmidt A; Guillaume N; Roques BP; Noble F
    Mol Pharmacol; 1998 May; 53(5):878-85. PubMed ID: 9584214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the receptor domains critical for the binding selectivity of delta-opioid receptor ligands.
    Meng F; Ueda Y; Hoversten MT; Thompson RC; Taylor L; Watson SJ; Akil H
    Eur J Pharmacol; 1996 Sep; 311(2-3):285-92. PubMed ID: 8891611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.